Research

The Literature

Lessons in Nonsurgical Glaucoma Management

Should SLT be performed as the initial treatment for glaucoma and ocular hypertension?

Jiun Lap Do, MD, PhD, and Naimul Alam, MD

Cover Focus

Examining the Genetic Architecture of Glaucoma

The discovery of new genetic markers has significant implications for predictive screening and disease prevention.

Stuart MacGregor, PhD

Cover Focus

Neurorecovery in Glaucoma

Using an optic nerve stress test to investigate cellular mechanisms.

Jonathan G. Crowston, MBBS, PhD, FRCOphth, FRANZCO; Katharina Bell, MD, PhD; Sevannah Ellis, PhD; Eamonn Fahy, FRANZCO; Lewis Fry, MBBS, DPhil; George Kong, MBBS, PhD, FRANZCO; and Vicki Chrysostomou, PhD

Cover Focus

Personalizing Angle-Closure Care

Identifying high-risk patients with OCT.

Austin Cho, BA, and Benjamin Y. Xu, MD, PhD

Patient Views

Patient Experience Data Collection

This information can provide regulatory authorities, payers, providers, and patient communities with a more holistic view of a therapy’s impact.

Richie Kahn, MPH, and Jenn McNary

The Literature

Visual Field Outcomes of Two Major Glaucoma Trials

Moving beyond IOP reductions measured in the clinic.

Sophia Y. Wang, MD, MS, and Robert T. Chang, MD

Editor's Page

The Observer Effect

Arsham Sheybani, MD

The Literature

Beyond the Retinal Nerve Fiber Layer

Recent data support macular ganglion cell analysis as a useful adjunct to monitor glaucomatous progression.

Anjali Bhorade, MD, MSCI, and Erin Sieck, MD

Patient Views

Working With Industry on R&D

How the sausage is made: an inside look at clinical trials from the patient perspective.

Richie Kahn, MPH

Cover Focus

Implementing Quality-of-Life Measures Into Glaucoma Clinical Trials

What are the next steps?

Richard K. Parrish II, MD; Lorraine M. Provencher, MD; and Gregory L. Skuta, MD

Cover Focus

Landmark Clinical Trial Findings Today: AGIS

What are the current applications of the outcomes of the Advanced Glaucoma Intervention Study?

Frank Chin, MD, and Eydie Miller-Ellis, MD

Cover Focus

Landmark Clinical Trial Findings Today: TVT

What are the current applications of the outcomes of the Tube Versus Trabeculectomy study?

Lilian Nguyen, MD

Cover Focus

Landmark Clinical Trial Findings Today: CIGTS

What are the current applications of the outcomes of the Collaborative Initial Glaucoma Treatment Study?

Catherine Q. Sun, MD

Cover Focus

Challenges in Clinical Trials

Certain requirements can delay, limit, or prohibit patient access to advances in glaucoma care.

George R. Reiss, MD

Research Update

Highlights of the 2020 AGS Annual Meeting

Results from clinical trials and research studies presented at the 30th annual meeting of the American Glaucoma Society in Washington, DC.

Geoffrey T. Emerick, MD

The Literature

Predicting Disease

Investigators explored ways to identify patients at increased risk of developing glaucoma or experiencing disease progression.

Cissy Yang, MD, and Noga Harizman, MD

Editorial Spotlight: Research Updates

Targeting Metabolic Vulnerabilities for Neuroprotection in Glaucoma

B₃ or not B₃? That is the question.

Pete A. Williams, PhD, and Jonathan G. Crowston, MBBS, FRCOphth, FRANZCO, PhD

Fuzzy Fiber: Behind the Scenes

A dialectic of hypothesis, experience, and resolution produced a new solution.

Khalid Lafdi, PhD

A Joint Structure-Function Model for Monitoring Glaucomatous Progression

Developing an individualized structure-function approach for early detection of progression.

Sampson Listowell Abu, OD; Koosha Ramezani, MD; Rongrong Hu, MD; Fang-I Chu, PhD; and Lyne Racette, PhD

Research Update

Highlights of the 2019 AGS Annual Meeting

Catch up on research comparing glaucoma surgical procedures, examining real-world diagnosis and treatment, and exploring the nature of the disease itself.

Sarwat Salim, MD, FACS, and Albert S. Khouri, MD